NEW YORK CITY: US pharmaceutical giant Pfizer will expand its line of drugs and therapies with the $17 billion takeover of Hospira, the two companies announced .

The deal, approved by the boards of both companies, will importantly add Hospira’s portfolio of sterile injectable treatments and biosimilar drugs to Pfizer’s broad pharma offerings.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details